Compare PRQR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRQR | TMCI |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.8M | 174.6M |
| IPO Year | 2014 | 2021 |
| Metric | PRQR | TMCI |
|---|---|---|
| Price | $1.69 | $2.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $8.14 | $4.21 |
| AVG Volume (30 Days) | 537.7K | ★ 707.1K |
| Earning Date | 03-12-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,859,556.00 | ★ $218,879,000.00 |
| Revenue This Year | N/A | $3.30 |
| Revenue Next Year | $18.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.90 |
| 52 Week Low | $1.07 | $2.36 |
| 52 Week High | $3.10 | $10.79 |
| Indicator | PRQR | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 38.10 |
| Support Level | $1.58 | $2.56 |
| Resistance Level | $1.80 | $2.75 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 13.67 | 14.62 |
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.